Apixaban Interactions
There are 395 drugs known to interact with apixaban, along with 4 disease interactions. Of the total drug interactions, 127 are major, 215 are moderate, and 53 are minor.
- View all 395 medications that may interact with apixaban
- View apixaban disease interactions (4)
Most frequently checked interactions
View interaction reports for apixaban and the medicines listed below.
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- Entresto (sacubitril / valsartan)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flomax (tamsulosin)
- Jardiance (empagliflozin)
- Lantus (insulin glargine)
- Lasix (furosemide)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Norco (acetaminophen / hydrocodone)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Ozempic (semaglutide)
- Paracetamol (acetaminophen)
- Plavix (clopidogrel)
- Spiriva (tiotropium)
- Symbicort (budesonide / formoterol)
- Synthroid (levothyroxine)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Apixaban disease interactions
There are 4 disease interactions with apixaban which include:
More about apixaban
- apixaban consumer information
- Compare alternatives
- Reviews (286)
- Imprints, shape & color data
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: factor Xa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.